An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors

被引:24
|
作者
Patel, Ami V. [1 ]
Chaney, Katherine E. [1 ]
Choi, Kwangmin [1 ]
Largaespada, David A. [3 ]
Kumar, Ashish R. [2 ]
Ratner, Nancy [1 ]
机构
[1] Univ Cincinnati, Cincinnati Childrens Hosp, Div Expt Hematol & Canc Biol, Dept Pediat, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Cincinnati Childrens Hosp, Div Bone Marrow Transplantat & Immune Deficiency, Dept Pediat, Cincinnati, OH 45229 USA
[3] Univ Minnesota, Dept Pediat, Masonic Canc Ctr, Minneapolis, MN 55455 USA
来源
EBIOMEDICINE | 2016年 / 9卷
关键词
MPNST; MEIS1; ID1; RNAi; p27(Kip); G0/G1; arrest; Sarcoma; NEUROFIBROMATOSIS TYPE-1 GENE; SELF-RENEWAL; STEM-CELLS; RNA INTERFERENCE; SCHWANN-CELLS; CANCER; LEUKEMIA; TRANSFORMATION; TUMORIGENESIS; EXPRESSION;
D O I
10.1016/j.ebiom.2016.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant peripheral nerve sheath tumors (MPNST) are rare soft tissue sarcomas that are a major source of mortality in neurofibromatosis type 1 (NF1) patients. To identify MPNST driver genes, we performed a lentiviral short hairpin (sh) RNA screen, targeting all 130 genes up-regulated in neurofibroma and MPNSTs versus normal human nerve Schwann cells. NF1 mutant cells show activation of RAS/MAPK signaling, so a counter-screen in RAS mutant carcinoma cells was performed to exclude common RAS-pathway driven genes. We identified 7 genes specific for survival of MPSNT cells, including MEIS1. MEIS1 was frequently amplified or hypomethylated in human MPSNTs, correlating with elevated MEIS1 gene expression. In MPNST cells and in a genetically engineered mouse model, MEIS1 expression in developing nerve glial cells was necessary for MPNST growth. Mechanistically, MEIS1 drives MPNST cell growth via the transcription factor ID1, thereby suppressing expression of the cell cycle inhibitor p27(Kip) and maintaining cell survival. (C) 2016 Published by Elsevier B.V.
引用
收藏
页码:110 / 119
页数:10
相关论文
共 50 条
  • [21] Alternative driver pathways in peripheral nerve sheath tumors - including DICER1 and/or KRAS alterations
    Chang, Hsin-Yi
    Saoud, Carla
    Torrence, Dianne
    Tap, William
    Chi, Ping
    Antonescu, Cristina R.
    JOURNAL OF PATHOLOGY, 2025, 265 (03) : 372 - 384
  • [22] Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
    Ahlawat, Shivani
    Blakeley, Jaishri O.
    Rodriguez, Fausto J.
    Fayad, Laura M.
    NEUROLOGY, 2019, 93 (11) : E1076 - E1084
  • [23] EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors
    Wu, J.
    Patmore, D. M.
    Jousma, E.
    Eaves, D. W.
    Breving, K.
    Patel, A. V.
    Schwartz, E. B.
    Fuchs, J. R.
    Cripe, T. P.
    Stemmer-Rachamimov, A. O.
    Ratner, N.
    ONCOGENE, 2014, 33 (02) : 173 - 180
  • [24] Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside
    Korfhage, Justin
    Lombard, David B.
    MOLECULAR CANCER RESEARCH, 2019, 17 (07) : 1417 - 1428
  • [25] Current Treatment Options for Malignant Peripheral Nerve Sheath Tumors
    Bradford, Diana
    Kim, AeRang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (03)
  • [26] Malignant and Benign Peripheral Nerve Sheath Tumors in a Single Center
    Jin, Zhenzhen
    Wang, Chao
    Wang, Dandan
    Li, Xintong
    Guo, Wen
    Chen, Tao
    JOURNAL OF ULTRASOUND IN MEDICINE, 2024, 43 (01) : 21 - 31
  • [27] Giant malignant peripheral nerve sheath tumors of the occipital scalp
    Wan, Shu
    Zhou, Hengjun
    Yu, Jianbo
    Ma, Yuehui
    Li, Jun
    Zhan, Renya
    ASIAN BIOMEDICINE, 2011, 5 (05) : 713 - 719
  • [28] Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors
    Yamashita, A. S.
    Baia, G. S.
    Ho, J. S. Y.
    Velarde, E.
    Wong, J.
    Gallia, G. L.
    Belzberg, A. J.
    Kimura, E. T.
    Riggins, G. J.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 118 (01) : 83 - 92
  • [29] Aberrant expression of CHFR in malignant peripheral nerve sheath tumors
    Kobayashi, C
    Oda, Y
    Takahira, T
    Izumi, T
    Kawaguchi, K
    Yamamoto, H
    Tamiya, S
    Yamada, T
    Iwamoto, Y
    Tsuneyoshi, M
    MODERN PATHOLOGY, 2006, 19 (04) : 524 - 532
  • [30] Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors
    Torres, Keila E.
    Zhu, Quan-Sheng
    Bill, Katelynn
    Lopez, Gonzalo
    Ghadimi, Markus P.
    Xie, Xianbiao
    Young, Eric D.
    Liu, Juehui
    Nguyen, Theresa
    Bolshakov, Svetlana
    Belousov, Roman
    Wang, Suizhau
    Lahat, Guy
    Liu, Jun
    Hernandez, Belinda
    Lazar, Alexander J.
    Lev, Dina
    CLINICAL CANCER RESEARCH, 2011, 17 (12) : 3943 - 3955